Connection

Karel Kostev to Infliximab

Back to Details
This is a "connection" page, showing publications Karel Kostev has written about Infliximab.
Karel Kostev
Connection Strength
0.561
Infliximab
  1. Prevalence of switching from two anti-TNF biosimilars back to biologic reference products in Germany?. Int J Clin Pharmacol Ther. 2019 Jun; 57(6):323-328.
    View in: PubMed
    Score: 0.561
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.